Timothy Alexander

Xtra Teases Muse 2 Cameras Ahead of U.S. Summer Launch WILMINGTON, DE — Xtra said it recently previewed its next-generation Muse 2 and Muse 2 Pro pocket cameras ahead of a planned U.S. launch in summer 2 […]

Orchestra BioMed Gains Second FDA Breakthrough Designation NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) said the U.S. Food and Drug Administration granted a second Breakthrough Device D […]

InterDigital Reports Q1 Results, Signs New Licensing Agreements WILMINGTON, DE — InterDigital, Inc. (Nasdaq: IDCC) recently reported first-quarter 2026 results that exceeded its guidance, driven by new licensing a […]

Palvella to Report Q1 Results, Host May 7 Conference Call WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) will report first-quarter 2026 financial results before market open on Thursday, May 7, and w […]

Donegal Group Reports Lower Q1 Profit as Losses Rise MARIETTA, PA — Donegal Group Inc. (Nasdaq: DGICA, DGICB) recently reported lower first-quarter 2026 earnings as higher weather-related and large-loss c […]

Axalta Reports Lower Profit on Costs, Maintains Sales in Q1 PHILADELPHIA, PA — Axalta Coating Systems Ltd. (NYSE: AXTA) reported lower first-quarter 2026 profit as higher costs and weaker volumes offset r […]

How Patron Support Keeps Chester County News Independent Local journalism in Chester County is at a turning point. Across Pennsylvania and the country, traditional newsrooms have shrunk or disappeared […]

Nantmeal Village: The Crossroads That Time Forgot to Change Morning arrives slowly in Nantmeal Village. A thin veil of mist hangs over the fields, softening the edges of split-rail fences and stone walls that […]

Neuronetics Grants Inducement Awards to Six New Employees MALVERN, PA — Neuronetics, Inc. (Nasdaq: STIM) granted restricted stock unit inducement awards to six new non-executive employees under its 2020 I […]

Toll Brothers to Release Q2 Results, Host May 20 Conference Call FORT WASHINGTON, PA — Toll Brothers, Inc. (NYSE: TOL) will report second-quarter fiscal 2026 results after market close on Tuesday, May 19, and will h […]

Omega Flex Reports Lower Q1 Profit on Higher Costs EXTON, PA — Omega Flex, Inc. (Nasdaq: OFLX) reported lower first-quarter 2026 earnings as higher raw material costs, tariffs and increased spending w […]

Mineralys to Report First-Quarter Results on May 6 RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) will report financial results for the first quarter ended March 31 on Wednesday, May 6, a […]

Vishay Launches Thin Film Submount Platform for Optical, RF Use MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH) introduced a thin film submount platform designed for optical transceivers, RF modules and a […]

Carpenter Technology Reports Higher Q3 Profit, Raises 2026 Outlook PHILADELPHIA, PA — Carpenter Technology Corporation (NYSE: CRS) reported higher third-quarter fiscal 2026 earnings and increased its full-year o […]

Ashland Reports Lower Profit, Cuts 2026 Outlook on Operational Issues WILMINGTON, DE — Ashland Inc. (NYSE: ASH) reported lower second-quarter fiscal 2026 profit despite a slight increase in sales and reduced its f […]

YPrime Launches AI Calculation Engine for Clinical Trial Platform MALVERN, PA — YPrime launched an AI-powered calculation engine within its eCOA platform to automate how clinical trial data calculations are c […]

QNB Corp. Reports Higher First-Quarter Earnings on Margin Growth QUAKERTOWN, PA — QNB Corp. (OTCQX: QNBC) recently reported first-quarter 2026 net income of $2,765,000, or $0.73 per diluted share, driven by higher n […]

ShowMojo Adds Property Shield to Detect Fraudulent Listings CLAYMONT, DE — ShowMojo has integrated Property Shield into its leasing platform to monitor rental listings for fraud, impersonation, and u […]

Cabaletta, Cellares Sign Manufacturing Deal for Rese-Cel Supply PHILADELPHIA, PA & SOUTH SAN FRANCISCO, CA — Cabaletta Bio, Inc. (Nasdaq: CABA) and Cellares have entered a commercial agreement to manufacture r […]

Annovis Bio Publishes Phase 2/3 Alzheimer’s Trial Results MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) recently published results from a Phase 2/3 clinical trial evaluating its investigational drug b […]